4//SEC Filing
BILINSKY IGOR 4
Accession 0001104659-25-056437
CIK 0001425205other
Filed
Jun 3, 8:00 PM ET
Accepted
Jun 4, 4:47 PM ET
Size
12.0 KB
Accession
0001104659-25-056437
Insider Transaction Report
Form 4
BILINSKY IGOR
Chief Operating Officer
Transactions
- Exercise/Conversion
Restricted Stock Units
2025-06-02−8,789→ 61,528 total→ Common stock (8,789 underlying) - Tax Payment
Common Stock
2025-06-02$1.76/sh−6,250$11,000→ 93,633 total - Exercise/Conversion
Restricted Stock Units
2025-06-02−3,516→ 10,549 total→ Common stock (3,516 underlying) - Exercise/Conversion
Common Stock
2025-06-02+12,305→ 99,883 total
Footnotes (7)
- [F1]Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date.
- [F2]Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities.
- [F3]Represents common stock remaining after deducting the common stock withheld for taxes.
- [F4]Each RSU represents a contingent right to receive one share of the Issuer's common stock.
- [F5]The remaining RSUs will vest in equal quarterly installments.
- [F6]Such aggregate number reflects the remainder of such RSUs granted on March 2, 2023, but does not include any other RSUs held by such Reporting Person.
- [F7]Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person.
Documents
Issuer
IOVANCE BIOTHERAPEUTICS, INC.
CIK 0001425205
Entity typeother
Related Parties
1- filerCIK 0001594604
Filing Metadata
- Form type
- 4
- Filed
- Jun 3, 8:00 PM ET
- Accepted
- Jun 4, 4:47 PM ET
- Size
- 12.0 KB